Richard L. Sherman
Mr. Sherman has twenty-five years of experience as a licensing executive, attorney, consultant, and venture capitalist in the biotechnology and pharmaceutical industries. As a licensing executive and Deputy General Counsel in a thirteen year career at SmithKline-Beckman Corporation, Mr. Sherman participated as counsel and negotiator in hundreds of international and domestic transactions; including hostile and friendly acquisitions, divestitures, joint ventures, limited partnerships, research and development collaborations, venture capital investments, joint marketing relationships, distribution arrangements, and licensing transactions. Mr. Sherman also founded QED Technologies, Inc., a consulting firm that provides science-based companies with experienced advice and counsel in developing and implementing strategies to maximize their business and technology assets. QED's clients include pharmaceutical, biotechnological, chemical, diagnostic and medical device firms; universities and independent research centers; investment groups and funds. QED was purchased by The Omnicom Group, Inc., a NYSE listed firm.